These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 28223679
1. Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17). Zhuo T, Zhou S, Zhang W, Lambertucci C, Volpini R. Med Sci Monit; 2017 Feb 22; 23():953-959. PubMed ID: 28223679 [Abstract] [Full Text] [Related]
2. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. Parravicini C, Ranghino G, Abbracchio MP, Fantucci P. BMC Bioinformatics; 2008 Jun 04; 9():263. PubMed ID: 18533035 [Abstract] [Full Text] [Related]
3. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry. Temporini C, Ceruti S, Calleri E, Ferrario S, Moaddel R, Abbracchio MP, Massolini G. Anal Biochem; 2009 Jan 01; 384(1):123-9. PubMed ID: 18835238 [Abstract] [Full Text] [Related]
4. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. Calleri E, Ceruti S, Cristalli G, Martini C, Temporini C, Parravicini C, Volpini R, Daniele S, Caccialanza G, Lecca D, Lambertucci C, Trincavelli ML, Marucci G, Wainer IW, Ranghino G, Fantucci P, Abbracchio MP, Massolini G. J Med Chem; 2010 May 13; 53(9):3489-501. PubMed ID: 20394377 [Abstract] [Full Text] [Related]
5. A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights. Parravicini C, Daniele S, Palazzolo L, Trincavelli ML, Martini C, Zaratin P, Primi R, Coppolino G, Gianazza E, Abbracchio MP, Eberini I. Cell Signal; 2016 Jun 13; 28(6):631-42. PubMed ID: 26971834 [Abstract] [Full Text] [Related]
6. Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice. Zhan TW, Tian YX, Wang Q, Wu ZX, Zhang WP, Lu YB, Wu M. Int Immunopharmacol; 2018 Sep 13; 62():261-269. PubMed ID: 30036769 [Abstract] [Full Text] [Related]
10. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction. Cosentino S, Castiglioni L, Colazzo F, Nobili E, Tremoli E, Rosa P, Abbracchio MP, Sironi L, Pesce M. J Cell Mol Med; 2014 Sep 13; 18(9):1785-96. PubMed ID: 24909956 [Abstract] [Full Text] [Related]
11. The G Protein-Coupled Receptor GPR17: Overview and Update. Marucci G, Dal Ben D, Lambertucci C, Santinelli C, Spinaci A, Thomas A, Volpini R, Buccioni M. ChemMedChem; 2016 Dec 06; 11(23):2567-2574. PubMed ID: 27863043 [Abstract] [Full Text] [Related]
12. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. Lecca D, Trincavelli ML, Gelosa P, Sironi L, Ciana P, Fumagalli M, Villa G, Verderio C, Grumelli C, Guerrini U, Tremoli E, Rosa P, Cuboni S, Martini C, Buffo A, Cimino M, Abbracchio MP. PLoS One; 2008 Dec 06; 3(10):e3579. PubMed ID: 18974869 [Abstract] [Full Text] [Related]
13. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach. Parravicini C, Abbracchio MP, Fantucci P, Ranghino G. BMC Struct Biol; 2010 Mar 16; 10():8. PubMed ID: 20233425 [Abstract] [Full Text] [Related]
14. Structural analysis of human G-protein-coupled receptor 17 ligand binding sites. Konda Mani S, Thiyagarajan R, Yli-Harja O, Kandhavelu M, Murugesan A. J Cell Biochem; 2023 Apr 16; 124(4):533-544. PubMed ID: 36791278 [Abstract] [Full Text] [Related]
15. General ligand affinity chromatography: N6-(6-aminohexyl) 3',5'-ADP Sepharose as an affinity adsorbent for the CoA-dependent enzyme, succinate thiokinase. Barry S, Brodelius P, Mosbach K. FEBS Lett; 1976 Nov 16; 70(1):261-6. PubMed ID: 992071 [No Abstract] [Full Text] [Related]
16. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. Eberini I, Daniele S, Parravicini C, Sensi C, Trincavelli ML, Martini C, Abbracchio MP. J Comput Aided Mol Des; 2011 Aug 16; 25(8):743-52. PubMed ID: 21744154 [Abstract] [Full Text] [Related]
17. GPR17 receptor modulators and their therapeutic implications: review of recent patents. Marucci G, Dal Ben D, Lambertucci C, Martí Navia A, Spinaci A, Volpini R, Buccioni M. Expert Opin Ther Pat; 2019 Feb 16; 29(2):85-95. PubMed ID: 30640576 [Abstract] [Full Text] [Related]
18. Identification of novel GPR17-agonists by structural bioinformatics and signaling activation. Saravanan KM, Palanivel S, Yli-Harja O, Kandhavelu M. Int J Biol Macromol; 2018 Jan 16; 106():901-907. PubMed ID: 28827203 [Abstract] [Full Text] [Related]
19. Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17. Pillaiyar T, Funke M, Al-Hroub H, Weyler S, Ivanova S, Schlegel J, Abdelrahman A, Müller CE. Eur J Med Chem; 2020 Jan 15; 186():111789. PubMed ID: 31727469 [Abstract] [Full Text] [Related]
20. Immobilized coenzymes in general ligand affinity chromatography and their use as active coenzymes. Mosbach K. Adv Enzymol Relat Areas Mol Biol; 1978 Jan 15; 46():205-78. PubMed ID: 24987 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]